| Dr Elena G Gozum, MD | |
|
54 W Countryside Parkway, Suite C, Yorkville, IL 60560 | |
| (630) 553-6262 | |
| (630) 553-6450 |
| Full Name | Dr Elena G Gozum |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 37 Years |
| Location | 54 W Countryside Parkway, Yorkville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275534471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 036-104554 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Medical Center | Peoria, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Spectranetics Corporation today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to hospitals for the Spectranetics Laser Sheath, which is used for the removal of problematic pacemaker and defibrillator cardiac leads.
Allan Coukell, director of the Pew Prescription Project, issued the following statement today, commending Congress for including provisions from the Physician Payments Sunshine Act in health care reform legislation.
EpiCept Corporation today announced that Nasdaq notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the Nasdaq Listing Qualification Panel (the "Panel") decision dated November 2, 2009. Accordingly, the Panel has determined to continue the listing of the Company's common stock on The Nasdaq Stock Market.
The "food-security arm of the Consultative Group on International Agricultural Research [CGIAR], a global alliance of agricultural experts," launched a report Friday at the U.N. climate change conference in Copenhagen that "calls for an intensive effort to speed the implementation of dozens of agriculture-related technologies in developing countries, which are the most vulnerable to climate change," the Globe and Mail reports.
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.
› Verified 8 days ago
| Entity Name | Allergy And Asthma Healthcare Clinic, Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134243934 PECOS PAC ID: 9739284472 Enrollment ID: O20070425000121 |
News Archive
Spectranetics Corporation today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to hospitals for the Spectranetics Laser Sheath, which is used for the removal of problematic pacemaker and defibrillator cardiac leads.
Allan Coukell, director of the Pew Prescription Project, issued the following statement today, commending Congress for including provisions from the Physician Payments Sunshine Act in health care reform legislation.
EpiCept Corporation today announced that Nasdaq notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the Nasdaq Listing Qualification Panel (the "Panel") decision dated November 2, 2009. Accordingly, the Panel has determined to continue the listing of the Company's common stock on The Nasdaq Stock Market.
The "food-security arm of the Consultative Group on International Agricultural Research [CGIAR], a global alliance of agricultural experts," launched a report Friday at the U.N. climate change conference in Copenhagen that "calls for an intensive effort to speed the implementation of dozens of agriculture-related technologies in developing countries, which are the most vulnerable to climate change," the Globe and Mail reports.
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.
› Verified 8 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Spectranetics Corporation today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to hospitals for the Spectranetics Laser Sheath, which is used for the removal of problematic pacemaker and defibrillator cardiac leads.
Allan Coukell, director of the Pew Prescription Project, issued the following statement today, commending Congress for including provisions from the Physician Payments Sunshine Act in health care reform legislation.
EpiCept Corporation today announced that Nasdaq notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the Nasdaq Listing Qualification Panel (the "Panel") decision dated November 2, 2009. Accordingly, the Panel has determined to continue the listing of the Company's common stock on The Nasdaq Stock Market.
The "food-security arm of the Consultative Group on International Agricultural Research [CGIAR], a global alliance of agricultural experts," launched a report Friday at the U.N. climate change conference in Copenhagen that "calls for an intensive effort to speed the implementation of dozens of agriculture-related technologies in developing countries, which are the most vulnerable to climate change," the Globe and Mail reports.
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elena G Gozum, MD 54 W Countryside Parkway, Suite C, Yorkville, IL 60560 Ph: (630) 553-6262 | Dr Elena G Gozum, MD 54 W Countryside Parkway, Suite C, Yorkville, IL 60560 Ph: (630) 553-6262 |
News Archive
Spectranetics Corporation today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to hospitals for the Spectranetics Laser Sheath, which is used for the removal of problematic pacemaker and defibrillator cardiac leads.
Allan Coukell, director of the Pew Prescription Project, issued the following statement today, commending Congress for including provisions from the Physician Payments Sunshine Act in health care reform legislation.
EpiCept Corporation today announced that Nasdaq notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the Nasdaq Listing Qualification Panel (the "Panel") decision dated November 2, 2009. Accordingly, the Panel has determined to continue the listing of the Company's common stock on The Nasdaq Stock Market.
The "food-security arm of the Consultative Group on International Agricultural Research [CGIAR], a global alliance of agricultural experts," launched a report Friday at the U.N. climate change conference in Copenhagen that "calls for an intensive effort to speed the implementation of dozens of agriculture-related technologies in developing countries, which are the most vulnerable to climate change," the Globe and Mail reports.
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a unanimous vote of 12 to 0 that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, be granted marketing approval by the FDA for the treatment of Dupuytren's contracture.
› Verified 8 days ago